Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

AHA Statement Zeroes In On Sleep Health

L.A. McKeown

April 17, 2025

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

L.A. McKeown

April 15, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Daily News

Aficamten Delivers Positive Results in SEQUOIA-HCM

Todd Neale

December 27, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Daily News

Microvascular Thrombi Common in Patients Dying of COVID-19

Michael O'Riordan

January 27, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

News Daily News

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Yael L. Maxwell

August 23, 2016

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

News Daily News

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

L.A. McKeown

October 23, 2012

News Daily News

Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality

L.A. McKeown

May 27, 2011

Advertisement

AHA Statement Zeroes In On Sleep Health

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

Top Heart Failure News of 2024

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Aficamten Delivers Positive Results in SEQUOIA-HCM

Top Heart Failure News of 2022

Microvascular Thrombi Common in Patients Dying of COVID-19

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Survival After Septal Ablation for HOCM Similar to General Population

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content